An Update on Repetitive Transcranial Magnetic Stimulation for the Treatment of Co-morbid Pain and Depressive Symptoms
Review recent meta-analyses and clinical trials investigating the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) for concurrent pain and depressive symptoms.
Recent meta-analyses have included both pain and depression outcomes in fibromyalgia and chronic pain. Randomized controlled trials have also been conducted in post-herpetic neuralgia, trauma-related headache, and neuropathic pain with attention to both pain and depressive symptoms. In general, studies have demonstrated reduction in pain in patients with fibromyalgia as an add-on treatment, post-herpetic neuralgia, trauma-related headache, and neuropathic pain. There are variable findings for reduction in depressive symptoms in patients with co-morbid pain disorders. Theta burst stimulation (TBS) is a novel rTMS protocol that has recently been investigated in patients with depression and some smaller trials in patients with co-morbid pain disorders. These emerging treatment options may have similar or greater therapeutic potency and may be delivered with greater efficiency.
There is evidence to support the use of rTMS for its analgesic effects in various pain syndromes. The variable results between trials for treatment of concurrent depressive symptoms may be due to heterogeneity in treatment protocols including parameters such as site of stimulation (primary motor cortex versus dorsolateral prefrontal cortex) and restrictions in the patient population which usually exclude primary psychiatric diagnoses. Future trials should work to standardize these protocols, investigate novel protocols like TBS, and continue to include standardized assessment of concurrent psychiatric outcomes such as depression and anxiety.
KeywordsTranscranial magnetic stimulation Depression Pain Fibromyalgia Headache Chronic pain
Compliance with Ethical Standards
Conflict of Interest
Jonathan Hsu declares no conflict of interest. Daniel Blumberger reports non-financial support (In Kind Equipment support for an investigator initiated trial) from Magventure, Site PI for 4 sponsored clinical trials from Brainsway, and served on the Advisory Board of Janssen, during the conduct of the study. Zafiris Daskalakis reports grants from Brainsway, and equipment support from Magventure outside the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 1.Hsu J, Blumberger DM. Transcranial magnetic stimulation in neuropsychiatry: an update. Psychiatric Times. 2015;32(2):12.Google Scholar
- 12.• Hou WH, Wang TY, Kang JH. The effects of add-on non-invasive brain stimulation in fibromyalgia: a meta-analysis and meta-regression of randomized controlled trials. Rheumatology (Oxford, England). 2016;55(8):1507–17. A comprehensive review of rTMS as an add-on treatment for fibromyalgia CrossRefGoogle Scholar
- 13.• Knijnik LM, Dussan-Sarria JA, Rozisky JR, et al. Repetitive transcranial magnetic stimulation for fibromyalgia: systematic review and meta-analysis. Pain practice: the official journal of World Institute of Pain. 2016;16(3):294–304. A good review of rTMS as the only intervention for fibromyalgia. CrossRefGoogle Scholar
- 14.Cleeland C, Ryan K. Pain assessment: global use of the Brief Pain Inventory. Singapore: Annals, Academy of Medicine; 1994.Google Scholar
- 16.Boldt I, Eriks-Hoogland I, Brinkhof MW, de Bie R, Joggi D, von Elm E. Non-pharmacological interventions for chronic pain in people with spinal cord injury. Cochrane Database Syst Rev. 2014;(11):Cd009177.Google Scholar
- 23.Bakker N, Shahab S, Giacobbe P, Blumberger DM, Daskalakis ZJ, Kennedy SH, et al. rTMS of the dorsomedial prefrontal cortex for major depression: safety, tolerability, effectiveness, and outcome predictors for 10 Hz versus intermittent theta-burst stimulation. Brain stimulation. 2015;8(2):208–15.CrossRefPubMedGoogle Scholar
- 25.Leung A, Metzger-Smith V, He Y, Cordero J, Ehlert B, Song D, Lin L, Shahrokh G, Tsai A, Vaninetti M, Rutledge T, Polston G, Sheu R, Lee R. Left dorsolateral prefrontal cortex rTMS in alleviating MTBI related headaches and depressive symptoms. Neuromodulation 2017.Google Scholar
- 31.• Moisset X, Goudeau S, Poindessous-Jazat F, Baudic S, Clavelou P, Bouhassira D. Prolonged continuous theta-burst stimulation is more analgesic than ‘classical’ high frequency repetitive transcranial magnetic stimulation. Brain Stimul. 2015;8(1):135–41. An initial trial investigating theta burst stimulation in pain as a novel rTMS protocol CrossRefPubMedGoogle Scholar
- 33.Lefaucheur JP, Ayache SS, Sorel M, Farhat WH, Zouari HG, Ciampi de Andrade D, et al. Analgesic effects of repetitive transcranial magnetic stimulation of the motor cortex in neuropathic pain: influence of theta burst stimulation priming. European journal of pain (London, England). 2012;16(10):1403–13.CrossRefGoogle Scholar